Data Insights: Identifying Early Signs of Safety and Efficacy in Oncology Clinical Trials

September 30, 2020
Read Now

White Papers

Load More

Industry News

Press Release
Laidlaw Venture Partners Portfolio Company Voltron Therapeutics Enters into Strategic Development Agreement With Translational Drug Development (TD2), a Precision Oncology Contract Research Organization (CRO)
November 24, 2020
Press Release
TD2 and VieCure Partner to Bring Best-in-Class Cancer Medicines and Access to Precision Oncology Clinical Trials to Patients in Community Oncology Practices
October 29, 2020
Press Release
Applied Clinical Trials: Small Biopharma and CROs: Seeking Stronger Synergies
September 28, 2020
Press Release
Ready to Make an Impact? Join Our Team.
July 16, 2020
Press Release
PM360: COVID-19’s Long-Lasting Impact on Clinical Trials
June 16, 2020
Press Release
RCT Acquires Translational Drug Development, LLC
June 04, 2020
Press Release
TD2 Business Continuity during COVID-19
March 25, 2020
Press Release
BioSpace: What Does 2020 Have in Store for Life Sciences?
January 16, 2020
Press Release
Genzada Pharmaceuticals Doses First Patient
April 10, 2019
Load More

Recent Blog Posts

Stay in Touch

Get free tips, tools and resources by subscribing to the TD2 newsletter.

Subscribe to the TD2 Newsletter.

Thank you.

Your request has been submitted. A member of our team will reach out to you shortly.

Move your research forward, smarter.